Ligand validation:2TSR

D16: TOMUDEX

D16 is a Ligand Of Interest in 2TSR designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2TSR_D16_C_509	44%	11%	0.221	0.949	2.44	1.81	12	9	1	0	100%	1
2TSR_D16_D_609	40%	12%	0.206	0.919	2.36	1.78	13	8	1	0	100%	1
2TSR_D16_A_309	26%	11%	0.247	0.889	2.51	1.74	12	8	0	0	100%	1
2TSR_D16_B_409	24%	12%	0.242	0.875	2.43	1.69	14	8	1	0	100%	1
4EB4_D16_A_402	79%	24%	0.086	0.931	1.45	1.68	4	7	1	0	100%	1
1RTS_D16_A_309	39%	11%	0.211	0.919	2.24	1.92	11	9	2	0	100%	1
7XYK_D16_D_302	89%	73%	0.076	0.956	0.36	0.68	-	1	0	0	100%	1
6ZXO_D16_B_401	74%	29%	0.125	0.954	1.42	1.44	3	5	2	0	100%	1
8GKF_D16_B_301	72%	52%	0.131	0.954	0.76	1.09	-	2	0	0	100%	1
3NRR_D16_A_530	71%	29%	0.112	0.933	1.59	1.28	5	2	0	0	100%	1
1HVY_D16_D_417	63%	7%	0.122	0.917	1.84	2.91	5	11	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.